S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RSLS ReShape Lifesciences Inc

0.1753

0.0083 (4.97%)

After Hours

Last Updated: 06:41:09

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences Inc News

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
Thursday 25 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 17 January 2024 (4 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 6 January 2024 (4 months ago) • Edgar (US Regulatory)

ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
Thursday 21 December 2023 (4 months ago) • GlobeNewswire Inc.

ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
Wednesday 13 December 2023 (5 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 30 November 2023 (5 months ago) • Edgar (US Regulatory)

More ReShape Lifesciences Inc News Articles

S&P ASX 300 Metals and M...

Australia And New Zealan...

Sterling vs AUD

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions